Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food ... injuries, and bleeding events. Do not donate blood, organs, tissues, or cells for transplantation following administration of BEQVEZ.

GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and ...

The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...

In 2023, Pfizer made more than $27 billion in revenue and paid zero federal income tax. Like many other large US companies, it took advantage ... declines in revenues” of Comirnaty, its COVID-19 ...

Most of the largest pharmaceutical companies report losing money in the United States, despite the majority of their sales ...

Drugmakers make big profits in the U.S. But many pay taxes far below the 21% corporate tax rate. Pfizer's effective tax rate is so low it's getting a big refund despite booking $59 billion in revenue.

The National Institute of Infectious Diseases (NIID) on May 14 reported Pfizer's COVID-19 vaccine lowers the chances of a recipient contracting the virus after about 12 days of the first shot.

Abrysvo is a bivalent vaccine that ... company stated. Pfizer also met its diversity recruitment goals for the study providing data from participants that mirror the diverse US population and ...

Pfizer Inc PFE stock is up 1.7% at $27.04 at last check, following news a late-stage trial of its respiratory syncytial virus (RSV) vaccine Abrysvo generated an immune response in higher risk ...

The company said it would submit the information to the US Food and Drug Administration for potential expansion of the vaccine’s availability to people ages 18 to 59. Pfizer’s RSV vaccine ...

It could be time for many Americans to add another vaccine to their list. Pfizer recently announced the results of a ... pneumococcal conjugate vaccine for children in Europe.” In the US, Prevanar 20 ...